Rabies

Rabies continues to pose a major global public health issue, especially in developing countries, as it is the deadliest viral zoonotic disease. The rabies virus predominantly targets mammals, with dogs being the main carriers and sources of infections in humans. Rabies is most often transmitted to humans through the bite of an animal that is infected with the virus. However, other modes of transmission, such as scratches or exposure to contaminated saliva, are also possible. The virus targets the central nervous system, leading to a range of neurological symptoms, including increased anxiety, restlessness, sensory disturbances, and difficulties with movement. Once clinical manifestations emerge, the rabies virus invariably culminates in a fatal outcome. Administering post-exposure prophylaxis promptly, which includes cleaning the wound and providing rabies vaccine and immunoglobulin, has been shown to be a highly effective method for preventing the disease from advancing. Interventions to control the spread of rabies emphasize vaccinating domestic dog populations, promoting public education on rabies prevention strategies, and guaranteeing availability of post-exposure prophylaxis for individuals who have been exposed to the virus. The elevated expenses associated with rabies treatment in certain areas highlight the necessity for readily available and economical post-exposure prophylaxis to avert avoidable mortalities from this preventable malady.